1. Short NJ, Rytting ME, Cortes JE. Acute myeloid leukaemia. Lancet. 2018;392(10147):593–606.
2. Surveillance Epidemiology and End Results (SEER) Program. Cancer stat facts: leukemia—acute myeloid leukemia (AML). 2021 [cited 2021 August 13]. Available from: https://seer.cancer.gov/statfacts/html/amyl.html.
3. Yu J, Jiang PYZ, Sun H, Zhang X, Jiang Z, Li Y, et al. Advances in targeted therapy for acute myeloid leukemia. Biomark Res. 2020;8(1):17.
4. Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Guideline Acute Myeloid Leukemia V.2.2021. © National Comprehensive Cancer Network, Inc. 2022. All rights reserved. Accessed August 14, 2021. To view the most recent and complete version of the guideline, go online to NCCN.org. NCCN makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way.
5. Sekeres MA, Guyatt G, Abel G, Alibhai S, Altman JK, Buckstein R, et al. American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults. Blood Adv. 2020;4(15):3528–49.